MEDILENS

TAX ID9591813075

Share capital1,202,200.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

Kozia 3a, 25-514 Kielce

Show on map

Register Data

Full name

MEDILENS SPÓŁKA Z OGRANICZONĄ ODPOWEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. KOZIA 3 A, 25-514 KIELCE

Show on map

NIP

9591813075

REGON

260218447

KRS

0000301882

Legal form

limited liability company

ALEO.com Registration Date

2013-12-02

Register Address

UL. KOZIA 3 A, 25-514 KIELCE

Date of registration in KRS

2008-03-19

Date of commencement of economic activity

2008-03-19

Act signature

RDF/618051/24/171

Pkd codes

86.10.Z - Hospital activities

47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores

68.10.Z - Buying and selling of own real estate

68.20.Z - Rental and operating of own or leased real estate

70.22.Z - Business and other management consultancy activities

72.19.Z - Other research and experimental development on natural sciences and engineering

84.12.Z - Regulation of the activities of providing health care, education, cultural services and other social services, excluding social security

85.59.B - Other out-of-school forms of education, not elsewhere classified

85.60.Z - Educational support activities

86.22.Z - Specialist medical practice activities

Payer VAT status

Active

Vat list bank account(s)

PL40 1130 1192 0027 6114 9620 0001

Company authorities

representation authorityMANAGEMENT

representation type

DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

MANAGEMENT

Janusz Antoni Cieślik

Member Of The Board, 70 years old

Ewa Maria Cieślik

Chairman Of The Board, 45 years old

Tomasz Janusz Cieślik

Member Of The Board, 42 years old

shareholders

Janusz Antoni Cieślik

50% 5981 udziałów o łącznej wartości 598.100 zł

Stanisława Cieślik

50% 5981 udziałów o łącznej wartości 598.100 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022
	M PLN	M PLN	%
Gross profit (loss)	0,8	1,2	45,6
EBITDA	1,1	1,5	29,2
Short time liabilities	0,7	0,6	-19,6
Equity capital	7	8,1	15,8
Operating profit (EBIT)	0,8	1,2	45,6
Assets	7,7	8,7	12,4
Net profit (loss)	0,8	1,1	40,1
Cash	2,6	2,7	4,5
Liabilities and provisions for liabilities	0,7	0,6	-19,6
Net income from sale	5,3	5,9	12
Working assets	2,9	3,2	8,8
Depreciation	0,3	0,3	-15,5
	%	%	p.p.
Profitability of capital	11,3	13,6	2,3
Equity capital to total assets	90,5	93,2	2,7
Gross profit margin	15,6	20,3	4,7
EBITDA Margin	21,4	24,7	3,3
	Days	Days	Days
Short term commitment turnover cycle	51	36	-15